MetaVia Inc. Files 8-K with Regulatory Updates
Ticker: MTVA · Form: 8-K · Filed: Jul 9, 2025 · CIK: 1638287
| Field | Detail |
|---|---|
| Company | Metavia INC. (MTVA) |
| Form Type | 8-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-disclosure
Related Tickers: MTVA
TL;DR
MetaVia Inc. (MTVA) filed an 8-K on 7/9/25. Expect updates.
AI Summary
MetaVia Inc. filed an 8-K on July 9, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as NeuroBo Pharmaceuticals, Inc. and Gemphire Therapeutics Inc., is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This filing indicates MetaVia Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing for regulatory and financial disclosures, not indicating immediate operational or financial distress.
Key Players & Entities
- MetaVia Inc. (company) — Registrant
- NeuroBo Pharmaceuticals, Inc. (company) — Former Company Name
- Gemphire Therapeutics Inc. (company) — Former Company Name
- July 9, 2025 (date) — Date of Report
FAQ
What specific events are being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in this header information.
What financial statements and exhibits are being filed?
The filing states 'Financial Statements and Exhibits' are included, but the content of these documents is not detailed in the provided text.
When was MetaVia Inc. previously known by other names?
MetaVia Inc. was formerly known as NeuroBo Pharmaceuticals, Inc. (name change date 20191231) and Gemphire Therapeutics Inc. (name change date 20150331).
What is MetaVia Inc.'s principal executive office address?
The principal executive offices are located at 545 Concord Avenue, Suite 210, Cambridge, Massachusetts 02138.
What is MetaVia Inc.'s SIC code?
MetaVia Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 9, 2025 regarding MetaVia Inc. (MTVA).